Depression treatment for Hollywood — measurement-based, 50 minutes away.

RECO Health treats major depressive disorder, persistent depressive disorder, and treatment-resistant depression 35 miles north of Hollywood — a 50-minute run up I-95 to Delray Beach. In-house psychiatry sequences pharmacotherapy by evidence rather than habit, and interventional options (rTMS and IV ketamine) are available on-site when two antidepressant trials fail. Every treatment plan is anchored by PHQ-9 measurement-based care, and level of care (PHP or IOP) is matched to severity from intake through step-down back to Hollywood Beach, Emerald Hills, or Hollywood Lakes.

Hollywood sits 35 miles south of RECO Health’s Delray Beach campus — a 50-minute run up I-95 outside of rush hour. For many residents of Hollywood Beach, Emerald Hills, Hollywood Lakes, Hollywood Hills, and Oakwood presenting with major depression, that distance is doing clinical work: it separates the environment where depressive routines have calcified from the environment where treatment actually happens. Most Hollywood clients pair partial hospitalization with on-site sober-living in Delray rather than commute I-95 daily during an acute episode.

Diagnostic formulation and severity staging

The intake evaluation for Hollywood clients begins with a DSM-5-TR-based diagnostic formulation, not a symptom checklist. A psychiatrist and licensed clinician work to distinguish major depressive disorder from persistent depressive disorder (dysthymia), bipolar II depression, adjustment disorder with depressed mood, and depression secondary to a general medical condition, substance use, or medication effect. The distinction is not academic — bipolar depression is destabilized by SSRI monotherapy, and adjustment reactions typically don’t warrant medication at all.

Severity and risk are anchored by validated instruments. PHQ-9 quantifies depressive severity and is repeated at every psychiatric visit. GAD-7 captures the anxiety load that co-travels with depression in most presentations. The Columbia-Suicide Severity Rating Scale (C-SSRS) documents ideation, intent, plan, and behavior. Laboratory workup — TSH, B12, folate, vitamin D, and comprehensive metabolic panel — rules out medical contributors that would otherwise be treated fruitlessly with an antidepressant.

Level-of-care assignment follows severity, not preference. PHP is used for severe episodes, acute suicidality that does not meet imminent inpatient criteria, and functional collapse. IOP is appropriate for moderate depression where the client can maintain safety and some daily structure between sessions.

Pharmacology sequenced by evidence, not habit

First-line pharmacotherapy for major depression is an SSRI (sertraline, escitalopram) or SNRI (venlafaxine, duloxetine), titrated to therapeutic dose and held for a 4-6 week response window before conclusions are drawn. Under-dosing is a more common cause of apparent SSRI failure than genuine non-response.

When a partial response occurs at adequate dose, augmentation precedes switching. Aripiprazole at 2-10 mg, lithium at levels of 0.6-0.8 mEq/L, quetiapine XR, or bupropion added to an SSRI have the strongest evidence base and are used ahead of a switch to a fourth agent. Bupropion is preferred where fatigue, hypersomnia, or sexual side effects dominate. Mirtazapine is preferred where insomnia and weight loss are prominent. In perimenopausal presentations, venlafaxine or duloxetine may address vasomotor symptoms alongside mood.

Treatment-resistant depression — defined as two failed adequate trials — is not managed by cycling through a fifth antidepressant. The client is staged for interventional treatment. Every medication decision is documented alongside PHQ-9 trajectory so that the next clinician, whether at RECO or a step-down provider in Broward County, inherits a record of what was tried, at what dose, for how long, and with what response.

Behavioral therapy modalities with evidence for depression

RECO Health’s depression treatment program runs behavioral therapy to protocol rather than as a loose collection of techniques. Cognitive Behavioral Therapy for depression (Beck protocol) targets the cognitive distortions — catastrophizing, personalization, mind-reading — that maintain depressive rumination, paired with behavioral experiments that test the accuracy of depressive predictions. Behavioral Activation, run standalone or as a CBT component, restores rewarding and mastery activities that have dropped out during the episode; the mechanism is contact with reinforcement, not “thinking positively.”

Interpersonal Therapy (IPT) is used where grief, role transition (job loss, divorce, relocation, retirement), interpersonal deficits, or role dispute are identifiable drivers. For clients whose depression is trauma-linked — a common presentation, particularly among clients with substance use histories — Cognitive Processing Therapy or EMDR is layered in once affect regulation is stable.

Acceptance and Commitment Therapy (ACT) is used where rigid experiential avoidance and values disconnection dominate the clinical picture. Motivational Interviewing (MI) supports engagement in ambivalent clients. Group therapy runs process-oriented and skills-based tracks; skills tracks draw from DBT for clients with affect dysregulation or self-injurious behavior.

Escalation pathway when medication and therapy aren’t enough

Roughly a third of clients with major depression will not achieve remission with two adequate antidepressant trials. RECO Health’s escalation pathway is defined in advance rather than assembled reactively after months of drift.

Repetitive transcranial magnetic stimulation (rTMS) is offered on-site for insurance-eligible treatment-resistant depression. The standard protocol delivers 10 Hz stimulation to the left dorsolateral prefrontal cortex — 3000 pulses at 120% of resting motor threshold, five days per week for six weeks, totaling approximately 36 sessions. Response is tracked with weekly PHQ-9. Theta-burst protocols are used where scheduling constraints or tolerability favor a shorter session.

IV ketamine (0.5 mg/kg infused over 40 minutes, six-infusion induction across 2-3 weeks) is used where suicidality, functional collapse, or catatonic features do not permit a six-week rTMS course. Esketamine (Spravato) is used where a REMS-monitored intranasal protocol is clinically or logistically preferred; monitoring includes blood pressure, dissociation ratings, and a two-hour post-dose observation window per label. Maintenance schedules are tapered based on PHQ-9 trajectory rather than fixed calendars.

What to expect on the first visit from Hollywood

Hollywood clients typically arrive at the Delray Beach campus by mid-morning to complete a comprehensive intake in a single visit. The first four hours cover psychiatric evaluation with a physician, biopsychosocial assessment with a licensed clinician, PHQ-9 and GAD-7 administration, C-SSRS documentation, and a review of prior treatment records — antidepressants tried, doses reached, duration, and response. A preliminary treatment plan is discussed the same day.

If PHP is indicated, sober-living or supportive housing options in Delray Beach are reviewed rather than routing the client into a daily 100-mile round trip during an acute episode. If IOP is appropriate, scheduling accommodates the I-95 commute — typically three-hour blocks three days per week, arranged around Hollywood work and childcare obligations.

Insurance and admissions from Hollywood

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans covering Hollywood and greater Broward County. Admissions verifies benefits at the initial call, including PHP and IOP session authorizations, rTMS coverage (which typically requires documented failure of two antidepressant trials from separate classes), and Spravato coverage where a REMS-certified site is required.

For clients on Florida Marketplace plans purchased through the ACA exchange, behavioral health is generally covered at parity with medical benefits — a distinction that matters clinically because a fully authorized 36-session rTMS course is often the difference between remission and chronic residual depression.

Serving residents of: Hollywood Beach, Emerald Hills, Hollywood Lakes, Hollywood Hills, Oakwood.